Value proposition

Aidian develops, manufactures and markets diagnostic tests and test solutions.

We are a leading Finnish-based in vitro diagnostics (IVD) company established in 1974. We develop, manufacture, and distribute reliable and fast diagnostic tests for point of care. Our aim is to aid global health by promoting efficient healthcare through accurate and fast diagnostics. We provide solutions to fight against antimicrobial resistance (AMR), one of the biggest threats to global health, and drive sustainable use of antibiotics in primary care. Testing before prescribing using fast and accurate point of care tests guides rational antibiotic prescribing.

High-quality products and patient safety are the core of our business. We specialize in point of care and our product portfolio provides solutions among others for infectious disease diagnostics, improved management of diabetes, and colorectal cancer screening. In addition, we provide easy to use products for hygiene monitoring for the use of hospitals and industries.

We have approximately 300 dedicated employees who want to be in the forefront of creating tools for better healthcare. In addition to our Head Quarters in Espoo, Finland, we have local offices in 12 different countries: Sweden, Norway, Denmark, Germany, Czech Republic, Slovakia, Hungary, Poland, the Netherlands, Belgium, Estonia, and China.

Our global footprint covers over 60 countries and our QuikRead go® flagship products are used globally, with over 60,000 instruments in use by our customers. We are fully compliant with the ISO 13485 Quality Standard as well as FDA requirements.

For further information visit aidian.eu or contact us by email: aidian@aidian.eu
Products available in the USA: aidian.eu/us/products-available-in-the-usa
Aidian's Privacy Policy: aidian.eu/privacy/privacy-policy

diagnostic tests, point-of-care, point-of-care diagnostic tools, hygiene monitoring tests, tests for infectious diseases, diagnostic test solutions, CRP test, rapid POC testing, POC testing, QuikRead go, isothermal nucleic acid amplification technology, SIBA, molecular biology, AMR, antimicrobial resistance, antibiotic resistance, in vitro diagnostics , and IVD